Sam Possemiers
Chief Executive Officer MRM Health
Seminars
Wednesday 28th January 2026
Advancing Rationally-Designed Microbial Consortia for Ulcerative Colitis and Beyond
9:30 am
- Presenting Phase 2b development of MH002 for ulcerative colitis and insights from earlier clinical trials
- Assessing MH002’s mode-of-action and highlighting the CORAL platform’s role in designing potent and scalable LBPs
- Exploring and future applications in pouchitis and immune-oncology through strategic partnerships and pipeline expansion
